Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Manipal Health EnterprisesNSE:MANIPALHOS -3.30%13 Return-on-Tangible-Equity is Negative Tangible Equity% as of Mar. 2026. GuruFocus rates NSE:MANIPALHOS with a GF Score™ of 13/100. The stock has 1 warning sign investors should review. Among 586 Healthcare Providers & Services companies, Manipal Health Enterprises ranks better than 99.83% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Manipal Health Enterprises's annualized net income for the quarter that ended in Mar. 2026 was ₹6,549 Mil. Manipal Health Enterprises's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ₹-24,707 Mil. Therefore, Manipal Health Enterprises's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was Negative Tangible Equity%.
The historical rank and industry rank for Manipal Health Enterprises's Return-on-Tangible-Equity or its related term are showing as below:
NSE:MANIPALHOS'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 71.48 Med: 71.48 Max: 71.48
Current: Negative Tangible Equity
During the past 3 years, Manipal Health Enterprises's highest Return-on-Tangible-Equity was 71.48%. The lowest was 71.48%. And the median was 71.48%.
NSE:MANIPALHOS's Return-on-Tangible-Equity is ranked better than 99.83% of 586
companies
in the Healthcare Providers & Services industry
Industry Median: 10.74
vs NSE:MANIPALHOS: Negative Tangible Equity
Manipal Health Enterprises (NSE:MANIPALHOS) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Manipal Health Enterprises Return-on-Tangible-Equity Related Terms
Manipal Health Enterprises Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Manipal Health Enterprises Return-on-Tangible-Equity Chart
Manipal Health Enterprises Annual Data
Trend
Mar24
Mar25
Mar26
Return-on-Tangible-Equity
71.48
Negative Tangible Equity
Negative Tangible Equity
Manipal Health Enterprises Semi-Annual Data
Mar24
Mar25
Mar26
Return-on-Tangible-Equity
71.48
Negative Tangible Equity
Negative Tangible Equity
NSE:MANIPALHOS vs HCA, THC, EHC: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Manipal Health Enterprises's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Manipal Health Enterprises Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Manipal Health Enterprises's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Manipal Health Enterprises's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is one times the annual (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of Negative Tangible Equity% mean?
Manipal Health Enterprises (NSE:MANIPALHOS) has a Return-on-Tangible-Equity of Negative Tangible Equity% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Manipal Health Enterprises and its competitors. Over the past decade, Manipal Health Enterprises' Return-on-Tangible-Equity has ranged from 71.48 to 71.48. According to the industry distribution chart, Manipal Health Enterprises ranks #1 out of 586 companies in the Healthcare Providers & Services industry, placing it in the top 0.2%.
Is Manipal Health Enterprises' Return-on-Tangible-Equity too high?
Manipal Health Enterprises' current Return-on-Tangible-Equity is Negative Tangible Equity%. Over the past 10 years, this metric has ranged from a low of 71.48 to a high of 71.48. Based on the distribution chart, Manipal Health Enterprises ranks #1 out of 586 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Manipal Health Enterprises has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Manipal Health Enterprises' Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Manipal Health Enterprises ranks #1 out of 586 companies for Return-on-Tangible-Equity. This places Manipal Health Enterprises in the top 0% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 10.74. Historically, Manipal Health Enterprises' own Return-on-Tangible-Equity has ranged from 71.48 to 71.48 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.74, based on 586 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Manipal Health Enterprises and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Manipal Health Enterprises's current Return-on-Tangible-Equity is Negative Tangible Equity%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Manipal Health Enterprises stock overvalued right now?
Manipal Health Enterprises (NSE:MANIPALHOS) has a current Return-on-Tangible-Equity of Negative Tangible Equity%. The current Return-on-Tangible-Equity is Negative Tangible Equity%. Manipal Health Enterprises' overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Manipal Health Enterprises (NSE:MANIPALHOS), the current Return-on-Tangible-Equity is Negative Tangible Equity% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Manipal Health Enterprises Ltd is engaged in the business of running/managing hospitals and providing healthcare services. The company operates through various Hospitals/clinics providing Healthcare services and diagnostic centres in India. It offers clinical services across several specialties, with a focus on tertiary and quaternary care, particularly in cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics, and renal sciences. It has a single business segment, namely engaged in the business of healthcare services. The company generates revenue by providing inpatient care at its hospitals.
13GF Score
Get the complete analysis for NSE:MANIPALHOS
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MANIPALHOS has been successfully added to your 
